518 related articles for article (PubMed ID: 20469967)
41. Regulation of gut inflammation and th17 cell response by interleukin-21.
Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
[TBL] [Abstract][Full Text] [Related]
42. Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease.
Peterson RL; Wang L; Albert L; Keith JC; Dorner AJ
Lab Invest; 1998 Dec; 78(12):1503-12. PubMed ID: 9881950
[TBL] [Abstract][Full Text] [Related]
43. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
[TBL] [Abstract][Full Text] [Related]
44. The presentation of haptenated proteins and activation of T cells in the mesenteric lymph nodes by dendritic cells in the TNBS colitis rat.
Ishiguro Y; Sakuraba H; Yamagata K; Munakata A
Ann N Y Acad Sci; 2004 Dec; 1029():346-7. PubMed ID: 15681777
[TBL] [Abstract][Full Text] [Related]
45. Anti-inflammatory intestinal activity of Abarema cochliacarpos (Gomes) Barneby & Grimes in TNBS colitis model.
da Silva MS; Sánchez-Fidalgo S; Talero E; Cárdeno A; da Silva MA; Villegas W; Souza Brito AR; de La Lastra CA
J Ethnopharmacol; 2010 Mar; 128(2):467-75. PubMed ID: 20083187
[TBL] [Abstract][Full Text] [Related]
46. Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion.
Liu Z; Jiu J; Liu S; Fa X; Li F; Du Y
J Autoimmun; 2007; 29(2-3):187-94. PubMed ID: 17804196
[TBL] [Abstract][Full Text] [Related]
47. Prevention of trinitrobenzene sulfonic acid-induced experimental colitis by oral administration of a poly(lactic-coglycolic acid) microsphere containing prostaglandin E₂ receptor subtype 4 agonist.
Okamoto T; Uemoto S; Tabata Y
J Pharmacol Exp Ther; 2012 May; 341(2):340-9. PubMed ID: 22300734
[TBL] [Abstract][Full Text] [Related]
48. Effects of Ginkgo biloba extract on inflammatory mediators (SOD, MDA, TNF-alpha, NF-kappaBp65, IL-6) in TNBS-induced colitis in rats.
Zhou YH; Yu JP; Liu YF; Teng XJ; Ming M; Lv P; An P; Liu SQ; Yu HG
Mediators Inflamm; 2006; 2006(5):92642. PubMed ID: 17392580
[TBL] [Abstract][Full Text] [Related]
49. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
50. Effect of Astragalus polysaccharides on expression of TNF-α, IL-1β and NFATc4 in a rat model of experimental colitis.
Yang M; Lin HB; Gong S; Chen PY; Geng LL; Zeng YM; Li DY
Cytokine; 2014 Dec; 70(2):81-6. PubMed ID: 25132256
[TBL] [Abstract][Full Text] [Related]
51. Effect of Trichinella spiralis intervention on TNBS-induced experimental colitis in mice.
Xu J; Yu P; Wu L; Liu M; Lu Y
Immunobiology; 2019 Jan; 224(1):147-153. PubMed ID: 30413272
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic effects of rectal administration of muscovite on experimental colitis in rats.
Chen Y; Chen Y; Liu WL; Zhou TH; Cai JT; Du Q; Wang LJ; Wu JG; Si JM
J Gastroenterol Hepatol; 2009 May; 24(5):912-9. PubMed ID: 19220658
[TBL] [Abstract][Full Text] [Related]
53. Recovery from TNBS-induced colitis leads to the resistance to recurrent colitis and an increased ratio of FOXP3 to CD3 mRNA.
Chen DF; Lu LG; Tao KZ; Lu ZJ; Yuan YZ
J Dig Dis; 2013 Nov; 14(11):587-95. PubMed ID: 23786412
[TBL] [Abstract][Full Text] [Related]
54. Thalidomide impairment of trinitrobenzene sulphonic acid-induced colitis in the rat - role of endothelial cell-leukocyte interaction.
Lienenlüke B; Stojanovic T; Fiebig T; Fayyazi A; Germann T; Hecker M
Br J Pharmacol; 2001 Aug; 133(8):1414-23. PubMed ID: 11498529
[TBL] [Abstract][Full Text] [Related]
55. Anti-inflammatory effect of Chang-An-Shuan on TNBS-induced experimental colitis in rats.
Mi H; Liu FB; Li HW; Hou JT; Li PW
BMC Complement Altern Med; 2017 Jun; 17(1):315. PubMed ID: 28619075
[TBL] [Abstract][Full Text] [Related]
56. The in vitro anti-inflammatory effects of recombinant anti-CD25 immunotoxin on lamina propria T cells of patients with inflammatory bowel disease are not sufficient to cure experimental colitis in mice.
Pfister K; Wittig BM; Jüngling B; Ecker KW; Barth S; Huhn M; Sasse S; Engert A; Mueller-Molaian I; Diehl V; Zeitz M; Stallmach A
Int J Colorectal Dis; 2002 Mar; 17(2):77-84. PubMed ID: 12014425
[TBL] [Abstract][Full Text] [Related]
57. Evidence for the critical role of interleukin-12 but not interferon-gamma in the pathogenesis of experimental colitis in mice.
Tozawa K; Hanai H; Sugimoto K; Baba S; Sugimura H; Aoshi T; Uchijima M; Nagata T; Koide Y
J Gastroenterol Hepatol; 2003 May; 18(5):578-87. PubMed ID: 12702051
[TBL] [Abstract][Full Text] [Related]
58. IL-17/IFN-γ interactions regulate intestinal inflammation in TNBS-induced acute colitis.
Jin Y; Lin Y; Lin L; Zheng C
J Interferon Cytokine Res; 2012 Nov; 32(11):548-56. PubMed ID: 23030668
[TBL] [Abstract][Full Text] [Related]
59. Study on the interactions between transplanted bone marrow-derived mesenchymal stem cells and regulatory T cells for the treatment of experimental colitis.
Zuo D; Liu X; Shou Z; Fan H; Tang Q; Duan X; Cao D; Zou Z; Zhang L
Int J Mol Med; 2013 Dec; 32(6):1337-44. PubMed ID: 24142133
[TBL] [Abstract][Full Text] [Related]
60. Effects of interleukin-4 or interleukin-10 gene therapy on trinitrobenzenesulfonic acid-induced murine colitis.
Xiong J; Lin YH; Bi LH; Wang JD; Bai Y; Liu SD
BMC Gastroenterol; 2013 Dec; 13():165. PubMed ID: 24314293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
